MYCN and neuroblastoma: In summary, our study provides the evidence identifying KLHL37 as a crucial regulator in the progression of MYCN-amplified neuroblastoma and provides valuable insights into the pathological mechanism of how N-Myc maintains high stability in neuroblastoma.